• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Spirit AeroSystems, Oyster Point Pharma, Snap And Other Big Gainers From Monday

    11/8/22 2:00:34 AM ET
    $ACMR
    $AMG
    $BLUE
    $BTU
    Industrial Machinery/Components
    Technology
    Investment Managers
    Finance
    Get the next $ACMR alert in real time by email

    U.S. stocks closed higher on Monday, with the Dow Jones surging more than 400 points. Here is the list of some big stocks recording gains in the previous session.

    • Digital World Acquisition Corp. (NASDAQ:DWAC) shares climbed 66.5% to settle at $29.10 on Monday amid recent reports suggesting Donald Trump could announce a 2024 presidential run this week. Digital World Acquisition Corp is the business combination partner of Trump Media & Technology Group.
    • Oyster Point Pharma, Inc. (NASDAQ:OYST) surged 38.6% to close at $11.57 after the company announced it will be acquired by Viatris for $11 per share.
    • Veru Inc. (NASDAQ:VERU) shares gained 34.5% to settle at $14.44 following publication of briefing documents ahead of the Nov. 9 FDA Adcom meeting for its COVID-19 treatment candidate.
    • ACM Research, Inc. (NASDAQ:ACMR) gained 27.7% to close at $8.44 after Jefferies upgraded the stock from Underperform to Hold.
    • Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) rose 25.9% to close at $39.73 after the company reported better-than-expected Q3 results.
    • Tupperware Brands Corporation (NYSE:TUP) gained 25.9% to settle at $5.06. Richard Goudis, Executive Vice Chair at Tupperware Brands, reported a large insider buy on November 7, according to a new SEC filing.
    • Certara, Inc. (NASDAQ:CERT) climbed 19.6% to close at $12.73 after Arsenal Capital Partners increased its investment in the company with a $449 million stock purchase.
    • Syneos Health, Inc. (NASDAQ:SYNH) gained 16.7% to $30.00. The stock may be rebounding after falling last week following worse-than-expected Q3 results and reduced FY22 revenue guidance.
    • Spirit AeroSystems Holdings, Inc. (NYSE:SPR) gained 16.2% to close at $27.22 after Wolfe Research upgraded the stock from Underperform to Peer Perform. The company also announced a private offering of $800 million of senior secured first lien notes due 2029.
    • Napco Security Technologies, Inc. (NASDAQ:NSSC) gained 14.2% to close at $28.20 following strong Q1 results.
    • Viatris Inc (NASDAQ:VTRS) gained 13.1% to close at $10.97 after the company announced it will acquire Oyster Point Pharma.
    • Triumph Bancorp, Inc. (NYSE:TBK) gained 11.8% to close at $55.18. Triumph Bancorp commenced a modified "Dutch Auction" tender offer to repurchase up to $100 million of its common stock.
    • Affiliated Managers Group, Inc. (NYSE:AMG) climbed 11.4% to close at $138.00 after the company reported better-than-expected Q3 EPS and sales results. The company also increased its buyback to a total of 5.8 million shares of common stock.
    • Peabody Energy Corporation (NYSE:BTU) jumped 11.2% to settle at $30.01 after the company and Coronado ended merger talks on Sunday.
    • bluebird bio, Inc. (NASDAQ:BLUE) gained 11.1% to close at $6.81 as the company posted a narrower quarterly loss.
    • Daqo New Energy Corp. (NYSE:DQ) jumped 10.8% to settle at $51.10 after the company announced a $700 million buyback program. The company also announced that its subsidiaries Xinjiang Daqo and Inner Mongolia Daqo had signed a five-year high-purity polysilicon supply agreement with a company in China.
    • Enel Chile S.A. (NYSE:ENIC) gained 10.6% to settle at $1.98.
    • Sea Limited (NYSE:SE) jumped 10.1% to close at $48.47 after JP Morgan upgraded the stock from Neutral to Overweight.
    • Comstock Resources, Inc. (NYSE:CRK) rose 10% to close at $20.28. The company recently posted upbeat Q3 results.
    • DISH Network Corporation (NASDAQ:DISH) gained 9.9% to settle at $14.67.
    • Snap Inc. (NYSE:SNAP) rose 9.5% to close at $10.01 in possible sympathy with Meta, which has gained amid reports suggesting it will announce layoffs this week.
    • Cvent Holding Corp. (NYSE:CVT) gained 8.1% to settle at $5.87. Cvent Holding recently reported better-than-expected Q3 sales.
    Get the next $ACMR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACMR
    $AMG
    $BLUE
    $BTU

    CompanyDatePrice TargetRatingAnalyst
    Certara Inc.
    $CERT
    3/6/2026$8.00Overweight → Equal Weight
    Barclays
    Certara Inc.
    $CERT
    2/27/2026$10.00Buy → Hold
    Craig Hallum
    Snap Inc.
    $SNAP
    2/10/2026$7.30Neutral → Buy
    Arete
    Viatris Inc.
    $VTRS
    2/9/2026$18.00Neutral → Buy
    UBS
    Snap Inc.
    $SNAP
    2/6/2026$5.50Sell → Hold
    Stifel
    Snap Inc.
    $SNAP
    2/5/2026$10.00Neutral → Buy
    BofA Securities
    Viatris Inc.
    $VTRS
    1/16/2026$15.00Hold → Buy
    Argus
    Comstock Resources Inc.
    $CRK
    1/16/2026$24.00Buy → Neutral
    BofA Securities
    More analyst ratings

    $ACMR
    $AMG
    $BLUE
    $BTU
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    June 7, 2024 - FDA Roundup: June 7, 2024

    For Immediate Release: June 07, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA announced that it has advised the manufacturers of the licensed and authorized COVID-19 vaccines that the COVID-19 vaccines (2024-2025 Formula) for use in the United States should be monovalent (single strain) JN.1 vaccines to more closely match cu

    6/7/24 3:46:22 PM ET
    $GERN
    $SRAX
    $SNAP
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Advertising
    Consumer Discretionary

    March 22, 2024 - FDA Roundup: March 22, 2024

    For Immediate Release: March 22, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA issued an emergency use authorization for Pemgarda (pemivibart) for the pre-exposure prophylaxis (prevention) of COVID-19 in certain adults and adolescents (12 years of age and older weighing at least 40 kilograms [about 88 pounds]).  Pemgarda is

    3/22/24 5:02:42 PM ET
    $SNAP
    $SRAX
    Computer Software: Programming Data Processing
    Technology
    Advertising
    Consumer Discretionary

    December 8, 2023 - FDA Approves First Gene Therapies to Treat Patients with Sickle Cell Disease

    For Immediate Release: December 08, 2023 Today, the U.S. Food and Drug Administration approved two milestone treatments, Casgevy and Lyfgenia, representing the first cell-based gene therapies for the treatment of sickle cell disease (SCD) in patients 12 years and older. Additionally, one of these therapies, Casgevy, is the first FDA-approved treatment to utilize a type of novel genome editing technology, signali

    12/8/23 11:12:21 AM ET
    $BLUE
    $VRTX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    $ACMR
    $AMG
    $BLUE
    $BTU
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    NAPCO Security Technologies Selected for Inclusion in the S&P SmallCap 600 Index

    AMITYVILLE, N.Y., March 9, 2026 /PRNewswire/ -- NAPCO Security Technologies, Inc. (NASDAQ:NSSC), one of the leading designers and manufacturers of high-tech electronic security devices, wireless recurring communication services for intrusion, fire alarm, access control and locking systems as well as a leading provider of school safety solutions today is announcing it has been selected for inclusion in the S&P SmallCap 600 Index, effective prior to the opening of trading on March 13, 2026.  The S&P SmallCap 600 Index measures the performance of small-capitalization companies that meet specific criteria for market capitalization, liquidity and financial viability. Inclusion in the index is wid

    3/9/26 4:23:00 PM ET
    $NSSC
    Telecommunications Equipment
    Telecommunications

    Veru Enrolls First Patient in Phase 2b PLATEAU Clinical Trial of Enobosarm and Semaglutide Combination for High Quality Weight Loss

    -- The Phase 2b study to assess enobosarm's ability to preserve lean mass, physical function, and bone as well as burn more fat to produce greater quality and quantity of weight loss in older patients with obesity receiving semaglutide -- -- Interim analysis expected in the first quarter calendar year 2027---- Final topline clinical data expected in the fourth quarter calendar year 2027-- MIAMI, FL, March 09, 2026 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ:VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced that it has enrolled the first patient in its Phase 2b PLATEAU

    3/9/26 8:30:00 AM ET
    $VERU
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Vertiv Holdings, Lumentum Holdings, Coherent, and EchoStar Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400, and S&P SmallCap 600

    NEW YORK, March 6, 2026 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices: NAPCO Security Technologies Inc. (NASD: NSSC) will replace Alexander & Baldwin Inc. (NYSE:ALEX) in the S&P SmallCap 600 effective prior to the opening of trading on Friday, March 13. An investor group comprised of MW Group and funds affiliated with DivcoWest and Blackstone Real Estate is acquiring Alexander & Baldwin in a deal that is expected to close soon, pending final closing conditions.The following changes to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600 will take effect before the market opens on M

    3/6/26 6:39:00 PM ET
    $AGX
    $AHRT
    $AIG
    Engineering & Construction
    Consumer Discretionary
    Real Estate
    Finance

    $ACMR
    $AMG
    $BLUE
    $BTU
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CHIEF EXECUTIVE OFFICER Feehery William F bought $200,000 worth of shares (24,096 units at $8.30), increasing direct ownership by 1% to 2,360,769 units (SEC Form 4)

    4 - Certara, Inc. (0001827090) (Issuer)

    11/12/25 4:44:55 PM ET
    $CERT
    Computer Software: Prepackaged Software
    Technology

    Chief Executive Officer Smith Scott Andrew bought $219,740 worth of shares (22,000 units at $9.99), increasing direct ownership by 8% to 314,807 units (SEC Form 4)

    4 - Viatris Inc (0001792044) (Issuer)

    8/13/25 6:08:30 PM ET
    $VTRS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Executive Officer Smith Scott Andrew bought $536,262 worth of shares (60,000 units at $8.94), increasing direct ownership by 26% to 292,807 units (SEC Form 4)

    4 - Viatris Inc (0001792044) (Issuer)

    5/14/25 6:00:11 PM ET
    $VTRS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACMR
    $AMG
    $BLUE
    $BTU
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Certara downgraded by Barclays with a new price target

    Barclays downgraded Certara from Overweight to Equal Weight and set a new price target of $8.00

    3/6/26 8:25:25 AM ET
    $CERT
    Computer Software: Prepackaged Software
    Technology

    Certara downgraded by Craig Hallum with a new price target

    Craig Hallum downgraded Certara from Buy to Hold and set a new price target of $10.00

    2/27/26 8:32:38 AM ET
    $CERT
    Computer Software: Prepackaged Software
    Technology

    Snap upgraded by Arete with a new price target

    Arete upgraded Snap from Neutral to Buy and set a new price target of $7.30

    2/10/26 7:58:39 AM ET
    $SNAP
    Computer Software: Programming Data Processing
    Technology

    $ACMR
    $AMG
    $BLUE
    $BTU
    SEC Filings

    View All

    SEC Form 144 filed by ACM Research Inc.

    144 - ACM Research, Inc. (0001680062) (Subject)

    3/5/26 4:05:28 PM ET
    $ACMR
    Industrial Machinery/Components
    Technology

    Amendment: SEC Form SCHEDULE 13G/A filed by Affiliated Managers Group Inc.

    SCHEDULE 13G/A - AFFILIATED MANAGERS GROUP, INC. (0001004434) (Subject)

    3/5/26 1:19:55 PM ET
    $AMG
    Investment Managers
    Finance

    SEC Form S-8 filed by ACM Research Inc.

    S-8 - ACM Research, Inc. (0001680062) (Filer)

    3/4/26 11:53:04 AM ET
    $ACMR
    Industrial Machinery/Components
    Technology

    $ACMR
    $AMG
    $BLUE
    $BTU
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Viatris Inc.

    4 - Viatris Inc (0001792044) (Issuer)

    3/10/26 7:03:54 PM ET
    $VTRS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Kilts James M converted options into 24,835 shares, increasing direct ownership by 18% to 161,257 units (SEC Form 4)

    4 - Viatris Inc (0001792044) (Issuer)

    3/10/26 7:03:50 PM ET
    $VTRS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Viatris Inc.

    4 - Viatris Inc (0001792044) (Issuer)

    3/10/26 7:03:50 PM ET
    $VTRS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACMR
    $AMG
    $BLUE
    $BTU
    Leadership Updates

    Live Leadership Updates

    View All

    Vertiv Holdings, Lumentum Holdings, Coherent, and EchoStar Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400, and S&P SmallCap 600

    NEW YORK, March 6, 2026 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices: NAPCO Security Technologies Inc. (NASD: NSSC) will replace Alexander & Baldwin Inc. (NYSE:ALEX) in the S&P SmallCap 600 effective prior to the opening of trading on Friday, March 13. An investor group comprised of MW Group and funds affiliated with DivcoWest and Blackstone Real Estate is acquiring Alexander & Baldwin in a deal that is expected to close soon, pending final closing conditions.The following changes to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600 will take effect before the market opens on M

    3/6/26 6:39:00 PM ET
    $AGX
    $AHRT
    $AIG
    Engineering & Construction
    Consumer Discretionary
    Real Estate
    Finance

    AMG Appoints G. Staley Cates to its Board of Directors

    Karen L. Alvingham to Retire from Board of Directors  WEST PALM BEACH, Fla., Feb. 26, 2026 (GLOBE NEWSWIRE) -- AMG, a strategic partner to leading independent investment management firms globally, today announced the appointment of G. Staley Cates to its Board of Directors (the "Board"), effective April 1, 2026; the Company also announced the forthcoming retirement of Karen L. Alvingham from the Board, effective April 1, 2026. Lady Alvingham was appointed to AMG's Board of Directors in January 2018. Mr. Cates served as the Vice Chairman of Southeastern Asset Management, Inc. ("Southeastern"), an independent global investment management firm, from 2015 through 2024, having served as Presi

    2/26/26 6:59:00 AM ET
    $AMG
    Investment Managers
    Finance

    Sunbit Appoints Shachar G. Scott as Chief Marketing Officer to Accelerate its Next Phase of Growth

    Veteran global marketing leader joins from Meta as Sunbit scales products, partnerships and infrastructure to serve millions more consumers Sunbit, the personalized financial partner for everyday life, today announced the appointment of Shachar G. Scott as Chief Marketing Officer, signaling a pivotal next chapter in the company's growth. Scott brings more than 25 years of experience building and scaling global brands across technology and consumer products with leadership roles at Meta (NASDAQ:META), Apple (NASDAQ:AAPL), Bumble (NASDAQ:BMBL) and Snap (NYSE:SNAP). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260212757677/en/S

    2/12/26 10:14:00 AM ET
    $AAPL
    $BMBL
    $META
    Computer Manufacturing
    Technology
    Computer Software: Programming Data Processing

    $ACMR
    $AMG
    $BLUE
    $BTU
    Financials

    Live finance-specific insights

    View All

    Sea Limited Reports Fourth Quarter and Full Year 2025 Results

    Sea Limited (NYSE:SE) ("Sea" or the "Company") today announced its financial results for the fourth quarter and full year ended December 31, 2025. In the fourth quarter of 2025, Sea's GAAP revenue was US$6.9 billion, up 38.4% year-on-year. The Company also achieved gross profit of US$3.0 billion, up 36.0% year-on-year, and net income of US$410.9 million, up 72.9% year-on-year. Adjusted EBITDA1 increased by 33.2% year-on-year to reach US$787.1 million. For the full year of 2025, Sea's GAAP revenue was US$22.9 billion, up 36.4% year-on-year, with gross profit growing 42.2% year-on-year to US$10.2 billion. Net income reached US$1.6 billion, as compared to net income of US$447.8 million for

    3/3/26 6:30:00 AM ET
    $SE
    Other Consumer Services
    Consumer Discretionary

    ACM Research Reports Fourth Quarter and Fiscal Year 2025 Results

    FREMONT, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- ACM Research, Inc. ("ACM") (NASDAQ:ACMR), a leading supplier of wafer processing solutions for semiconductor and advanced packaging applications, today reported financial results for its fourth quarter and fiscal year ended December 31, 2025. "2025 was a year of strong execution for ACM," said ACM's President and Chief Executive Officer, Dr. David Wang. "We delivered record annual revenue of $901 million, up 15% year over year, outperforming estimated China WFE. We strengthened our foundation for long-term growth by advancing new products, expanding our global production capacity, and enhancing global funding initiatives." Dr. Wang conti

    2/26/26 7:00:00 AM ET
    $ACMR
    Industrial Machinery/Components
    Technology

    Viatris Reports Fourth-Quarter and Full-Year 2025 Financial Results

    Reports Fourth-Quarter Total Revenues of $3.7B and Full-Year 2025 Total Revenues of $14.3BMeets or Exceeds 2025 Financial Guidance Across All Key Metrics[1]Returns More Than $1B to Shareholders in 2025; Expects Balanced Capital Allocation Approach for 2026Provides 2026 Financial Guidance; Positioned for Sustainable GrowthAnticipates Regulatory Decisions for Six Product Candidates in 2026 and Multiple Important Pipeline MilestonesCompletes Enterprise-Wide Strategic Review; Expects to Deliver $650M in Total Cost Savings With Reinvestment of up to $250M Over the Next 3 YearsPITTSBURGH, Feb. 26, 2026 /PRNewswire/ -- Viatris Inc. (NASDAQ:VTRS) today announced robust financial results for the four

    2/26/26 6:59:00 AM ET
    $VTRS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACMR
    $AMG
    $BLUE
    $BTU
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Spirit Aerosystems Holdings Inc.

    SC 13G/A - Spirit AeroSystems Holdings, Inc. (0001364885) (Subject)

    11/14/24 5:12:55 PM ET
    $SPR
    Military/Government/Technical
    Industrials

    Amendment: SEC Form SC 13G/A filed by bluebird bio Inc.

    SC 13G/A - bluebird bio, Inc. (0001293971) (Subject)

    11/14/24 4:39:36 PM ET
    $BLUE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13G/A filed by bluebird bio Inc.

    SC 13G/A - bluebird bio, Inc. (0001293971) (Subject)

    11/14/24 4:27:32 PM ET
    $BLUE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care